Increased evidence implies that melatonin may be a promising molecule for combating
COVID-19 due to its potent antioxidative, anti-inflammatory and immunoregulatory …

The coronavirus, COVID-19, has infected hundreds of thousands and killed tens of
thousands of individuals worldwide. This highly infectious condition continues to ravage the …

The fear of SARS-CoV-2 infection is due to its high mortality related to seasonal flu. To date,
few medicines have been developed to significantly reduce the mortality of the severe …

The pharmacological properties of melatonin are well known. However, there is noticeable
the lack of clinical trials that confirm the efficacy, security, absence of side effects in the short …

The recent pandemic of COVID-19 has already infected millions of individuals and has
resulted in the death of hundreds of thousands worldwide. Based on clinical features …

SARS-CoV-2 has ravaged the population of the world for two years. Scientists have not yet
identified an effective therapy to reduce the mortality of severe COVID-19 patients. In a …

The high mortality of deadly virus infectious diseases including SARS, MERS, COVID-19,
and avian flu is often caused by the uncontrolled innate immune response and destructive …

Viral infections are dangerous diseases for human health worldwide, which lead to
significant morbidity and mortality each year. Because of their importance and the lack of …

To the Editor, We were pleased to read the publication by Lan et al. 1 which included a meta‐
analysis of the randomized controlled trials (RCTs) in which melatonin was used as a …

The SARS-CoV-2 pandemic is a global health concern still ongoing. No single therapeutic
intervention with high efficacy exists and virus mutations continue to improve immune …